Westlake (WLK) has just posted Q1 2026 results that follow a tough run of earnings, with recent quarterly revenue figures ranging from about US$2.5 billion to US$3.0 billion and EPS moving from a small profit in late 2024 to losses through 2025. Over that span, revenue has moved from US$3,117 million in Q3 2024 to US$2,533 million in Q4 2025, while basic EPS has shifted from US$0.83 to a loss of US$4.23. This has left investors focused squarely on how quickly margins can stabilize from here.

See our full analysis for Westlake.

With the latest numbers on the table, the next step is to set these results against the big narratives around Westlake, to see which stories still hold up and which are challenged by the recent margin profile.

Larger trailing losses, modest revenue base

• On a trailing twelve month basis to Q4 2025, Westlake generated about US$11.2b of revenue but reported a net loss of US$1.5b, equivalent to basic EPS of US$11.70 in losses.
• Consensus narrative points to expected revenue growth of 4.6% a year and profit margins moving from a loss of 13.4% to a 2.8% margin by 2029. This sits against recent quarterly results where revenue stayed around US$2.5b to US$3.0b, while net income swung from a small profit of US$7 million in Q4 2024 to losses as large as US$778 million in Q3 2025. The thesis of steadier growth therefore rests on a clear turn from this loss making base.
  • Analysts also expect earnings to reach US$364.4 million by 2029 versus the trailing US$1.5b loss, which would be a very large swing in profitability compared with the recent pattern of negative EPS each quarter of 2025.
  • To line up with that consensus path, you would be weighing today’s loss profile against the idea of gradual margin repair in both Performance and Essential Materials and Housing and Infrastructure Products over several years rather than a quick fix.

Loss making today, but bulls focus on margin repair

• Over the last reported four quarters of 2025, Westlake’s quarterly net income moved from a loss of US$40 million in Q1 to US$141 million in Q2, then US$778 million in Q3 and US$542 million in Q4, while basic EPS over that stretch ranged from a loss of US$0.31 to a loss of US$6.07 per share.
• Bullish investors argue that cost cuts and footprint changes can help margins recover, pointing to a planned US$600 million earnings uplift in 2026 from the 3 pillar plan and targeted HIP EBITDA margins of 19% to 21%. These goals currently sit against trailing twelve month margins that produced a US$1.5b loss on US$11.2b of revenue and quarterly losses running into the hundreds of millions, so the bullish case leans heavily on execution rather than anything already visible in the recent income statement.
  • The bullish narrative also assumes revenue can grow 6.0% annually with profit margins moving from a loss of 13.4% to a 4.1% margin, which is a noticeable step up from the current pattern where even quarters with higher revenue, such as US$2.953b in Q2 2025, still showed a net loss of US$141 million.
  • Supporters of this view may point to management’s comments around integration between PEM and HIP and lower capital spending of about US$900 million in 2026, but the hard numbers today remain those losses of US$952 million to US$1.5b on a trailing basis, which means the turnaround story is not yet reflected in reported EPS.

On these figures, if you want to see how bullish investors connect the 3 pillar plan and housing demand to a margin recovery story, it is worth reading their full argument in the 🐂 Westlake Bull Case.

Valuation looks full while bears stress slower growth

• Westlake trades on a P/S ratio of 1.2x versus 1.1x for the wider US Chemicals industry and 0.8x for peers, and the current share price of US$104.78 also sits above a DCF fair value of US$83.88.
• Bears highlight that this richer valuation multiple comes at a time when the company is unprofitable and revenue is forecast to grow at only 3.1% a year. They argue this combination could limit upside, especially given trailing losses of US$1.5b and a dividend yield of 2.02% that is not covered by earnings or free cash flow, so the concern is that investors are paying up against both weaker profitability and slower growth than the broader US market rate of 11.2% a year.
  • Cautious views also point out that the stock trades above the stated DCF fair value of US$83.88, suggesting little room for disappointment if earnings improvement or the targeted cost savings slip relative to the planned US$600 million uplift.
  • The flagged risk that the 2.02% dividend is not supported by current cash generation reinforces this bearish angle, because any pressure on liquidity from ongoing losses could leave less room to support both payouts and the roughly US$900 million of 2026 capital expenditure that has been outlined.

If you are weighing these concerns against the current share price and loss profile, it can help to read how cautious investors frame the downside in the 🐻 Westlake Bear Case.

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Westlake on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

Mixed signals on growth, margins and valuation can feel unsettled, so it helps to look at the full picture yourself and decide what matters most for your approach. If you want a concise view of both the red flags and the potential upside before making a call, check out the 1 key reward and 2 important warning signs.

Explore Alternatives

Westlake is working from a loss making base, with hundreds of millions in quarterly losses, an uncovered dividend and a valuation that already looks full.

If that mix of weak profitability and uncovered payouts feels uncomfortable, shift your attention to 72 resilient stocks with low risk scores so you can focus on companies with more resilient profiles.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.